We previously showed that a fraction of the acetyls used to synthesize malonyl-CoA in rat heart derives from partial peroxisomal oxidation of very long and long-chain fatty acids. The 13 C labeling ratio (malonylCoA)/(acetyl moiety of citrate) was >1.0 with 13 C-fatty acids, which yields [
Malonyl-CoA plays an important role in the regulation of fuel selection by the heart through its potent inhibition of carnitine palmitoyltransferase-I and of mitochondrial fatty acid oxidation (1) . Malonyl-CoA is synthesized by acetyl-CoA carboxylase 2, which appears to be attached to the outer membrane of mitochondria facing the cytosol (2, 3) . Because the heart is a non-lipogenic organ, the only known fate of malonyl-CoA is its decarboxylation by malonyl-CoA decarboxylase. Thus acetylCoA carboxylase and malonyl-CoA decarboxylase catalyze an acetyl-CoA 3 malonyl-CoA 3 acetyl-CoA substrate cycle that regulates malonyl-CoA concentration and mitochondrial fatty acid oxidation. The regulation of acetyl-CoA carboxylase and malonyl-CoA decarboxylase in the heart has been extensively investigated. For recent reviews, see Refs. 4 -8. Because the cytosolic concentrations of acetyl-CoA and malonyl-CoA are much lower than the K m of acetyl-CoA carboxylase and malonyl-CoA decarboxylase for their corresponding substrates, the concentrations of these substrates may regulate the fluxes through the enzymes. We recently measured the turnover of malonyl-CoA in isolated rat hearts perfused with NaH 13 CO 3 (9) . Under conditions where the malonyl-CoA concentration varied over a 5-fold range, this concentration was directly proportional to the acetyl-CoA carboxylase flux, but the total activities of acetyl-CoA carboxylase and malonyl-CoA decarboxylase (measured in tissue extracts) did not vary. This strongly supports the notion that in the heart the cytosolic concentration of acetyl-CoA is a major determinant of the concentration of malonyl-CoA and of the rate of mitochondrial fatty acid oxidation.
The acetyl-CoA used by cytosolic acetyl-CoA carboxylase is believed to be transferred from mitochondria either via acetylcarnitine or citrate and ATP-citrate lyase. We recently showed that a fraction of this acetyl-CoA is derived from the partial peroxisomal oxidation of long-chain or very long-chain fatty acids (10) . This conclusion was based from the comparison of the 13 C labeling of malonyl-CoA and the acetyl moiety of citrate, a proxy for mitochondrial acetyl-CoA. The labeling ratio (malonyl-CoA)/(acetyl moiety of citrate) was smaller than 1.0 in the presence of substrates that yield labeled acetyl-CoA only in mitochondria ( . This demonstrated that a fraction of the acetyl-CoA used for malonyl-CoA synthesis is formed in the extramitochondrial space, most likely in peroxisomes, probably via the straightchain fatty acid ␤-oxidation system (11) .
The present study takes advantage of the isotopic techniques we developed to further investigate various aspects of the regulation of peroxisomal and mitochondrial fatty acid oxidation specifically (i) the relative affinity of the two processes for low fatty acid concentrations, (ii) whether acetyl-CoA derived from peroxisomal oxidation is released as acetate, (iii) the effect of fatty acid chain length on peroxisomal oxidation, (iv) whether dodecanedioate is oxidized in mitochondria of the intact heart, and (v) the relative capacity of fatty acids of different chain length to generate mitochondrial acetyl-CoA. (14) . ATP-citrate lyase was prepared from the livers of rats that had been starved for 2 days and then refed for 3 days with a high glucose diet. The enzyme, isolated from the Bio-Gel column (15) , was precipitated with 50% ammonium sulfate, and aliquots of the suspension (2 units/0.1 ml) were kept frozen at Ϫ80°C. Before use, the enzyme was dissolved in 1 ml of 250 mM Tris-HCl, pH 8.7, containing 5 mM dithiothreitol.
Heart Perfusion Experiments-Male Sprague-Dawley rats (250 -300 g) were fed ad libitum for 10 -12 days with standard laboratory chow. Rats were anesthetized with sodium pentobarbital (60 mg⅐kg Ϫ1 ) injected intraperitoneally after overnight fasting prior to removal of the heart. Hearts were perfused in the Langendorf mode (12 ml/min) with non-recirculating bicarbonate buffer containing 3% dialyzed bovine serum albumin (fatty acid-free, Intergen), 4 Analytical Procedures-The 13 C labeling of malonyl-CoA was assayed by gas chromatography-mass spectrometry as described previously (12) , except that (i) we isolated the short-chain CoA esters on an Oasis cartridge (Waters), and (ii) malonate was assayed as the t-butyldimethylsilyl derivative (monitoring m/z 333-336). For the assay of the malonyl-CoA concentration, samples of frozen tissues were spiked with an internal standard of [U- 13 C 3 ]malonyl-CoA before extraction. The 13 C labeling of the acetyl moiety of heart citrate (a probe of mitochondrial acetyl-CoA) was assayed by cleaving citrate with ATP-citrate lyase isolated from rat liver (15) and analyzing acetyl-CoA by ion trap liquid chromatography-mass spectrometry (10) . Because of the poor solubility of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]docosanoate, its perfusate concentration was assayed (as the trimethylsilyl derivative) using a standard curve built with unlabeled docosanoate and an internal standard of [1,2,3,4-13 C 4 ]docosanoate. In some experiments, the 13 C labeling of acetate in the effluent perfusate (16) of tissue succinyl-CoA (17), acetylcarnitine (18) , and citrate (10) were assayed as described previously.
Data Presentations and Statistics-We present data from ϳ60 heart perfusion experiments. For each of the experimental conditions chosen (see Fig. 6 ), we ran 5-10 perfusions in the presence of selected 13 Clabeled substrate(s) with the concentration parameters being allowed to vary. Data shown in the figures are the M1 and M2 13 C enrichments of tissue malonyl-CoA, acetyl moiety of citrate, and acetylcarnitine measured in a given heart perfusion. They represent means of duplicate gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry injections, respectively, which differed by Ͻ2%. The statistical significance of differences between the 13 C enrichments of malonyl-CoA and the acetyl moiety of citrate in each set of experiments was tested using a paired t test (Graph Pad Prism Software, version 3).
RESULTS AND DISCUSSION
To probe peroxisomal and mitochondrial fatty acid oxidation, we perfused rat hearts with a number of 13 C-labeled fatty acids at different concentrations and measured the enrichment of malonyl-CoA (a probe of extramitochondrial acetyl-CoA) and of the acetyl moiety of citrate (a probe of mitochondrial acetylCoA) (Figs. [1] [2] [3] [4] [5] . When the enrichment of the acetyl moiety of citrate was measurable, we calculated the 13 C labeling ratio (malonyl-CoA)/(acetyl moiety of citrate) (see Fig. 6 ). The fatty acids investigated range from those believed to be oxidized only in peroxisomes (dodecanedioate and docosanoate) to those believed to be oxidized only in mitochondria (hexanoate, butyrate, and acetate).
Experiments with Dodecanedioate-In hearts perfused with 0 -0.8 mM [1,12-13 C 2 ]dodecanedioate ( Fig. 1 ), the enrichment of the acetyl moiety of citrate, and thus of mitochondrial acetylCoA, was undetectable in all cases. To confirm this absence, we assayed the labeling of citrate and succinyl-CoA; these intermediates of the citric acid cycle should be labeled from mitochondrial acetyl-CoA. Citrate was assayed as its trimethyl derivative to minimize its natural enrichment (10%). Consistent with the data for the acetyl moiety of citrate, there was no detectable labeling in citrate or succinyl-CoA. Note that these hearts were perfused without competing fatty acids, which might have decreased any contribution of [1,12- 13 C 2 ]dodecanedioate to mitochondrial acetyl-CoA. Thus, it appears that dodecanedioate, or acetyl groups derived from its extramitochondrial degradation, was not oxidized in the mitochondria of the intact heart. However, one cannot exclude a very small and undetectable contribution, i.e. Ͻ1%, of dodecanedioate to mitochondrial acetyl-CoA.
Vamecq and Draye (19) reported that isolated heart mitochondria can oxidize 0.08 mM dodecanedioyl-CoA in the presence of 0.35 mM carnitine. The oxidation of dodecanedioyl-CoA was reflected by the reduction of ferricyanide. It is not clear whether the observations of Vamecq and Draye (19) reflect (i) a very low rate of mitochondrial oxidation, which would be undetectable in the intact heart or (ii) the presence of peroxisomes in their mitochondrial preparation. Indeed, in intact liver cells, there is good evidence that dodecanedioate is oxidized only in peroxisomes (19 -22 In the same hearts perfused with 0 -0.8 mM [1,12- 13 C 2 ]dodecanedioate, the enrichment of malonyl-CoA plateaued at 9% (Fig. 1) . The labeling of malonyl-CoA in the absence of a detectable label in mitochondrial acetyl-CoA (Fig. 1) can only be explained by the peroxisomal oxidation of [1,12- 13 C 2 ]dodecanedioate, followed by the transfer of labeled acetyl groups to the cytosol. It is not clear how this transfer occurs in the heart. In the liver, part of the acetyl groups derived from peroxisomal oxidation are released as free acetate. We assayed the concentration and labeling of acetate in the effluent perfusate. Only minute traces of unlabeled acetate were detected. Thus, peroxisomal oxidation of dodecanedioate in the heart is not accompanied by the release of acetate. Also, we did not find any detectable label in tissue acetylcarnitine (Fig. 1) . Our data argue against the transport of acetyl groups out of heart peroxisomes via acetylcarnitine. There are conflicting data on the involvement of a carnitine acetyltransferase in the transfer of acetyl groups from peroxisomes to the cytosol. Although Connock and Perry (24) reported that a small fraction of the carnitine acetyltransferase of mouse heart is peroxisomal, Abbas et al. (25) reported the absence of cytosolic carnitine acetyltransferase in the extramitochondrial space of rat heart. In a recent review, Ramsay and Zammit (26) evoked the possibility that acyl-CoAs might cross the peroxisomal membrane without transient formation of acylcarnitine. Therefore, the mechanism of the transfer of peroxisomal acetyl-CoA to the cytosol needs to be further studied.
Can our data shed light on the number of cycles of oxidation undergone by [1,12- 13 C 2 ]dodecanedioate in heart peroxisomes? The maximal number of such cycles is four, which would generate [
13 C]succinyl-CoA. Because the tissue succinyl-CoA was unlabeled, it is unlikely that [1,12-13 C 2 ]dodecanedioate went through the maximal number of four peroxisomal oxidation cycles. If [1, [12] [13] C 2 ]dodecanedioate went through 1, 2, or 3 cycles of oxidation, the initial enrichment of the acetyl-CoA produced would be 100, 50, or 33%, respectively. This initial enrichment is decreased by two processes, (i) unlabeled acetylCoA transferred from mitochondria and (ii) unlabeled acetylCoA formed in peroxisomes from the oxidation of unlabeled, endogenous fatty acids (10) . The data of our experiment do not allow us to assess these dilution factors. However, we can conclude that at least 9% of the acetyl-CoA used for malonylCoA synthesis was derived from the peroxisomal oxidation of 0.8 mM [1, [12] [13] C 2 ]dodecanedioate. Although our data do not yield rates of [1, [12] [13] C 2 ]dodecanedioate oxidation in heart peroxisomes, Fig. 1 shows that this oxidation reaches half of its maximal value at ϳ0.1 mM of substrate.
Experiments with Docosanoate (22:0)-Because of the poor solubility of docosanoate, even in the presence of 3% bovine serum albumin, we assayed the concentration of [1-
13 C]docosanoate in the inflowing perfusate (see "Experimental Procedures"). In hearts perfused with 0 -0.1 mM [1-
13 C]docosanoate (Fig. 2) , the enrichment of malonyl-CoA plateaued at 11%, but the enrichments of the acetyl moiety of citrate and of citrate were undetectable in all cases. This indicated the absence of labeling of mitochondrial acetyl-CoA. In previous experiments with 0.1 mM [1,2,3,4-13 C 4 ]docosanoate (10), the enrichment of the acetyl moiety of citrate was 3-4%, while the enrichment of malonyl-CoA was 40%. The data from the two labeled forms of docosanoate yield complementary information. First, docosanoyl-CoA does not enter the mitochondria of the intact heart. Second, it appears that after one cycle of peroxisomal oxidation, [ Arguing against this possibility are (i) the absence of labeling of the acetyl moiety of citrate and (ii) the absence of detectable label in tissue acetylcarnitine (Fig. 2) in the presence of [1- 13 C]docosanoate. Furthermore, the absence of detectable labeling of the acetyl moiety of citrate while malonyl-CoA, and thus cytosolic acetyl-CoA, was 11% labeled (Fig. 2) argues against a substantial transport of cytosolic acetyl-CoA to mitochondria in the heart. The perfused rat liver oxidizes docosanoate only through peroxisomes and releases acetate in the medium (14) . We assayed the concentration and labeling of acetate in the effluent perfusate. No labeling of acetate was detected. Thus, in contrast to what occurs in the liver, peroxisomal oxidation of docosanoate in the heart is not accompanied by the release of acetate. Our data show that the peroxisomal oxidation of docosanoate is a high affinity process because, at a concentration of [1- 13 C]docosanoate of 0.02 mM, the malonyl-CoA enrichment was half of its maximum value (Fig. 2) .
Experiments with Oleate-In the presence of [1-13 C]oleate, the enrichment of malonyl-CoA rose sharply and linearly (r 2 ϭ 0.98) between 0 and 0.2 mM [1-13 C]oleate, then plateaued at ϳ12% at [1- 13 C]oleate concentrations equal or greater than 0.2 mM (Fig. 3) . The enrichment of the acetyl moiety of citrate increased progressively with the [1-
13 C]oleate concentration but remained lower than the enrichment of malonyl-CoA. Thus, in all cases, the labeling ratio (malonyl-CoA)/(acetyl moiety of citrate) was Ͼ1.5, especially at a low [1- 13 C]oleate concentration (Fig. 6) . This high labeling ratio shows that (i) oleate is oxidized in both peroxisomes and mitochondria, and (ii) the peroxisomal oxidation of oleate is a high affinity process compared with mitochondrial oxidation. However, mitochondrial oxidation of oleate is a high capacity process as indicated by the contribution of oleate to mitochondrial acetyl-CoA (ϳ80% at 0.8 mM [1-
13 C]oleate, see Fig. 8A ). is a low capacity process based on the reported activities of the enzymes involved, in particular acyl-CoA oxidase (27) .
Experiments with Medium-and Short-chain Fatty AcidsRat liver peroxisomes have a high capacity to oxidize octanoylCoA (28 -30) . We reported that, in livers perfused with nonrecirculating perfusate containing [1- 13 C]octanoate, the enrichment of effluent acetate was 37%; that is greater than the highest possible value for mitochondrial acetyl-CoA (25%). It also was up to twice that of ketone bodies (14) . There is evidence that, in liver, octanoate undergoes at least one cycle of peroxisomal ␤-oxidation and that the first acetyl of octanoate is released, at least in part, as free acetate (14) . In addition, acyl-CoA oxidase of human liver peroxisomes has high activity for the CoA esters of octanoate, dodecanoate, and palmitate (27) . We could not find any reference on the peroxisomal oxidation of octanoate in the intact heart. We only found reports that octanoyl-CoA is oxidized either by a medium-chain oxidase in isolated peroxisomes from rat hearts (31) or by a fatty acyl-CoA oxidase in rat heart homogenates (32) .
To test whether the peroxisomes of the intact heart can oxidize octanoate, we perfused hearts with increasing concentrations of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]octanoate (Fig. 4) . At low [1- (Figs. 4 and 6) . This indicates that, in the heart, [1- To test whether octanoate can undergo more than one cycle of peroxisomal oxidation, we perfused hearts with [3- 13 C]-octanoate (Fig. 5) . We found that the enrichment of acetyl moiety of citrate plateaued at 21%, which is almost identical to that of [1- 13 C]octanoate perfused hearts (22%). However, the enrichment of malonyl-CoA plateaued at 13%, which is half of that of [1- 13 C]octanoate (25%). Thus, the relative profiles of enrichment from [3- 13 C]octanoate of malonyl-CoA and the acetyl moiety of citrate (Fig. 5) were markedly different from those obtained with [1- 13 C]octanoate (Fig. 4) . At all [3-13 C]octanoate concentrations, the enrichment of the acetyl moiety of citrate was greater than that of malonyl-CoA, and the labeling ratio (malonyl-CoA)/(acetyl of citrate) ranged from 0.3 to 0.7 (Fig. 6 ). This clearly shows that the second acetyl group of octanoate is not converted to acetyl-CoA in peroxisomes. As an additional control, we perfused hearts with [1- 13 C]hexanoate, and the labeling ratio (malonyl-CoA)/(acetyl of citrate) ranged from 0.3 to 0.7 (Fig. 6) , as was the case for [3- 13 C]octanoate. Lastly, we perfused hearts with increasing concentrations of [1- 13 C]butyrate or [1,2-13 C 2 ]acetate. These fatty acids are only oxidized in mitochondria. Again, the labeling ratio (malonylCoA)/(acetyl of citrate) ranged from 0.2 to 0.7 (Fig. 6) .
Whether or not the heart has a cytosolic acetyl-CoA synthetase is not entirely clear from the old literature. Recently, Fujino et al. (33) reported that most of heart acetyl-CoA synthetase activity (AceCS2) is mitochondrial, with a very small fraction of the activity in the cytosol (AceCS1) (see Fig. 4 of Ref. 33) . This is an important question in relation to malonyl-CoA metabolism, because a cytosolic synthetase could convert plasma acetate to acetyl-CoA used for malonyl-CoA synthesis. Our data argue against a cytosolic activation of acetate because, in the presence of [U- 13 C 2 ]acetate (this study, Fig. 6 ) or [U- 13 C 6 ]glucose (Table I of Ref. 10), the enrichment of malonylCoA was about 40% that of the acetyl moiety of citrate (Fig. 6) . Labeling of extramitochondrial acetyl-CoA from [U- 13 C 6 ]-glucose can only occur via export of mitochondrial acetyl-CoA. Thus, the similar dilutions (malonyl-CoA)/(acetyl of citrate) with [U- 13 C 2 ]acetate and [U- 13 C 6 ]glucose show that no substantial activation of acetate occurs in heart cytosol.
In summary, (i) octanoate undergoes one cycle of peroxisomal oxidation in the heart, and (ii) hexanoate and short-chain fatty acids are oxidized only in mitochondria. In all experiments described above, only minute traces of acetate (Ͻ0.03 mM) were assayed without any detectable enrichment. This contrasts with the release of labeled acetate from (i) rat liver peroxisomes incubated with [1- C]octanoate (14) . Therefore, unlike the situation in liver (34, 35) , peroxisomal oxidation in rat heart is not accompanied by the hydrolysis of acetyl-CoA and release of acetate. We extensively reviewed this matter in the literature, especially the papers by Alexson and co-workers (36) who characterized acetyl-CoA thioesterase in liver peroxisomes, but we could not find any reference to acetyl-CoA thioesterase in heart peroxisomes.
Malonyl-CoA concentration increased linearly (r 2 ϭ 0.95) in hearts perfused with [1- 13 C] and [3-13 C]octanoate (Fig. 7) . This increase presumably inhibited the oxidation of endogenous, unlabeled long-chain fatty acids. No such correlation between tissue malonyl-CoA concentration and perfusate fatty acid concentration was observed with the other fatty acids (not shown). Our data are in agreement with results that malonyl-CoA concentration is higher in hearts perfused with octanoate than in hearts perfused with palmitate or oleate (37, 38) .
Contribution of Fatty Acids of Various Chain Lengths to Mitochondrial
Acetyl-CoA-The data from the experiments with the fatty acids that label the acetyl moiety of citrate allow one to calculate the contribution of these fatty acids to mitochondrial acetyl-CoA and thus to energy production by the heart. The contribution to mitochondrial acetyl-CoA of a fatty acid labeled in one of its acetyl moieties is calculated by multiplying the enrichment of the acetyl moiety of citrate by the number of acetyl groups in the fatty acid molecule (Fig. 8A) . The contributions of C 2 -C 18 fatty acids to mitochondrial acetylCoA, plotted as a function of the fatty acid millimolar concentrations, are remarkably similar (Fig. 8A) . These contributions plateau at 80 -90% for fatty acid concentrations of 0.8 mM. Our data are in agreement with reports that fatty acids contribute 60 -90% to energy production in the normal heart (39 -43) . The data in Fig. 8A can be replotted with the concentration of inflowing fatty acids expressed as millimolar acetyl units (Fig.  8B) . Then, for similar supplies of acetyl units, the efficiency of fatty acids as precursors of mitochondrial acetyl-CoA varies inversely with their chain length. For example, 1 mM acetyl from acetate or oleate contributes 82 or 24%, respectively, to mitochondrial acetyl-CoA. This ranking is observed also within the group of fatty acids that do not use the carnitine acyl transferase system to enter mitochondria (C 2 -C 8 ). This is quite surprising if one considers the energetics of the formation of acetyl-CoA from the various fatty acids. Fig. 9 shows the calculated average ATP yield or cost of converting one acetyl group of the various fatty acids to acetyl-CoA. These were calculated from the stoichiometry of all reactions involved from the activation of the fatty acid, to the production of ATP from the oxidation of FADH 2 and NADH (44) . This yield decreases with the fatty acid chain length. Although making mitochondrial acetyl-CoA from oleate yields on average 4 mol of ATP/mol of acetyl-CoA, making acetyl-CoA from acetate costs 2 mol of ATP/mol of acetyl-CoA. Thus, the oxidation to CO 2 of one mol of acetyl derived from acetate or oleate yields 14 or 20 mol of ATP, respectively. The high contribution to mitochondrial acetylCoA of low energy yielding acetate is puzzling. Therefore, the mechanism of the ranking of fatty acids as precursors of mitochondrial acetyl-CoA deserves further investigation.
In summary, the peroxisomal oxidation of n-fatty acids with 8 or more carbons (and of dodecanedioate) in the intact heart is a high affinity, low capacity process, which is not accompanied by the production of free acetate. The efficiency of the contribution of C 2 -C 18 fatty acids to mitochondrial acetyl-CoA, and thus to energy production of the heart, decreases with the fatty acid chain length. Our data also demonstrate that (i) octanoate undergoes only one cycle of peroxisomal ␤-oxidation, (ii) dodecanedioate and docosanoate are oxidized only in peroxisomes, and (iii) there is no detectable transfer to the mitochondria of acetyl-CoA from the cytosol or the peroxisomes. The latter two conclusions will be revisited using high sensitivity techniques such as gas chromatography-pyrolysis-isotope ratio mass spectrometry.
